{"id":76225,"date":"2026-10-15T02:09:25","date_gmt":"2026-10-15T02:09:25","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76225"},"modified":"2026-10-15T02:09:25","modified_gmt":"2026-10-15T02:09:25","slug":"u-s-analyst-updates-october-14th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/","title":{"rendered":"U.S. Analyst Updates: October 14th, 2026"},"content":{"rendered":"<h2><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76225&amp;preview=true\"><strong>Analyst Ratings (USA)<\/strong><\/a><\/h2>\n<p>Analyst sentiment for today&#8217;s updates is selective and cautious. Target cuts outnumbered increases, especially among banks, technology hardware and consumer stocks, while energy and materials attracted some upgrades and positive new coverage. The outlook points to opportunities in individual stocks rather than broad confidence across the market.<\/p>\n<h3><strong>Updates (418)<\/strong><\/h3>\n<p><strong>AAON (AAON)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating and lowered its price target to US$115.00 from US$125.00.<\/p>\n<p><strong>Acushnet (GOLF)<\/strong> \u2014 Stephens lowered its price target to US$81.00 from US$88.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Advanced Drainage Systems (WMS)<\/strong> \u2014 RBC Capital lowered its price target to US$170.00 from US$178.00 and retained its Outperform rating.<\/p>\n<p><strong>AGNT, Inc. (AGNT)<\/strong> \u2014 Citizens initiated coverage with a Market Outperform rating and a US$6.00 price target.<\/p>\n<p><strong>Albemarle (ALB)<\/strong> \u2014 Mizuho upgraded the stock to Outperform from Neutral and set a US$130.00 price target.<\/p>\n<p><strong>Albertsons Companies (ACI)<\/strong> \u2014 BofA Securities changed its rating on the stock to Underperform from Neutral and lowered its price target to US$12.00 from US$16.00.<\/p>\n<p><strong>Albertsons Companies (ACI)<\/strong> \u2014 RBC Capital raised its price target to US$16.00 from US$13.00 and retained its Outperform rating.<\/p>\n<p><strong>Albertsons Companies (ACI)<\/strong> \u2014 UBS Group reiterated its Neutral rating.<\/p>\n<p><strong>Albertsons Companies (ACI)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$12.00 from US$11.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Alcoa (AA)<\/strong> \u2014 Barclays initiated coverage with an Overweight rating and a US$55.00 price target.<\/p>\n<p><strong>Alector (ALEC)<\/strong> \u2014 HC Wainwright raised its price target to US$8.00 from US$5.00 and retained its Buy rating.<\/p>\n<p><strong>Align Technology (ALGN)<\/strong> \u2014 Leerink Partners lowered its price target to US$215.00 from US$235.00 and retained its Outperform rating.<\/p>\n<p><strong>AllianceBernstein (AB)<\/strong> \u2014 Barclays lowered its price target to US$37.00 from US$39.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Alliant Energy (LNT)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating and set a US$75.00 price target.<\/p>\n<p><strong>Alliant Energy (LNT)<\/strong> \u2014 RBC Capital set a US$75.00 price target.<\/p>\n<p><strong>Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 Citigroup lowered its price target to US$320.00 from US$340.00 and retained its Buy rating.<\/p>\n<p><strong>Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 Wells Fargo &amp; Company lowered its price target to US$253.00 from US$256.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Alphabet (GOOG)<\/strong> \u2014 UBS Group reiterated its Neutral rating and raised its price target to US$380.00 from US$379.00.<\/p>\n<p><strong>Alphabet (GOOGL)<\/strong> \u2014 UBS Group reiterated its Neutral rating and raised its price target to US$380.00 from US$379.00.<\/p>\n<p><strong>Ameren (AEE)<\/strong> \u2014 Truist Financial lowered its price target to US$116.00 from US$120.00 and retained its Buy rating.<\/p>\n<p><strong>American Homes 4 Rent (AMH)<\/strong> \u2014 Barclays lowered its price target to US$35.00 from US$36.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Americas Silver (USAS)<\/strong> \u2014 Stifel initiated coverage with a Buy rating.<\/p>\n<p><strong>Amplitude (AMPL)<\/strong> \u2014 BofA Securities raised its price target to US$16.50 from US$14.00 and retained its Neutral rating.<\/p>\n<p><strong>Amprius Technologies (AMPX)<\/strong> \u2014 Canaccord Genuity initiated coverage with a Buy rating and a US$14.00 price target.<\/p>\n<p><strong>Anglo American (NGLOY)<\/strong> \u2014 JPMorgan upgraded the stock to Neutral from Underweight.<\/p>\n<p><strong>Anteris Technologies Global (AVR)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating and set a US$15.00 price target.<\/p>\n<p><strong>Antero Resources (AR)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$46.00 price target.<\/p>\n<p><strong>APA (APA)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$44.00 price target.<\/p>\n<p><strong>APA (APA)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$51.00 from US$50.00 and retained its Equal Weight rating.<\/p>\n<p><strong>AppFolio (APPF)<\/strong> \u2014 KeyCorp reiterated its Overweight rating.<\/p>\n<p><strong>Applied Materials (AMAT)<\/strong> \u2014 RBC Capital reiterated its Outperform rating and set a US$600.00 price target.<\/p>\n<p><strong>AppLovin (APP)<\/strong> \u2014 Goldman Sachs lowered its price target to US$400.00 from US$465.00 and retained its Neutral rating.<\/p>\n<p><strong>AppLovin (APP)<\/strong> \u2014 Wedbush lowered its price target to US$560.00 from US$610.00 and retained its Outperform rating.<\/p>\n<p><strong>Aprea Therapeutics (APRE)<\/strong> \u2014 Ladenburg Thalmann initiated coverage with a Buy rating and a US$2 price target.<\/p>\n<p><strong>Arcus Biosciences (RCUS)<\/strong> \u2014 JPMorgan initiated coverage with an Overweight rating and a US$41.00 price target.<\/p>\n<p><strong>Argenex (ARGX)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$1,356.00 from US$1,355.00 and retained its Overweight rating.<\/p>\n<p><strong>Ascentage Pharma (AAPG)<\/strong> \u2014 Citigroup initiated coverage with a Buy rating and a US$46 price target.<\/p>\n<p><strong>Atlassian (TEAM)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$230.00 from US$180.00 and retained its Overweight rating.<\/p>\n<p><strong>Autohome (ATHM)<\/strong> \u2014 Jefferies reiterated its Buy rating and set a US$26.50 price target.<\/p>\n<p><strong>Axsome Therapeutics (AXSM)<\/strong> \u2014 RBC Capital reiterated its Outperform rating.<\/p>\n<p><strong>AZZ (AZZ)<\/strong> \u2014 Barclays initiated coverage with an Equal Weight rating and a US$140.00 price target.<\/p>\n<p><strong>Ballard Power Systems (BLDP)<\/strong> \u2014 Susquehanna lowered its price target to US$2.00 from US$3.00 and retained its Neutral rating.<\/p>\n<p><strong>BankUnited (BKU)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$52.00 from US$54.00 and retained its Overweight rating.<\/p>\n<p><strong>Beam Therapeutics (BEAM)<\/strong> \u2014 Wedbush reiterated its Outperform rating and set a US$65.00 price target.<\/p>\n<p><strong>Bilibili (BILI)<\/strong> \u2014 Citigroup lowered its price target to US$26.50 from US$27.00 and retained its Buy rating.<\/p>\n<p><strong>BioMarin Pharmaceutical (BMRN)<\/strong> \u2014 Barclays raised its price target to US$114.00 from US$111.00 and retained its Overweight rating.<\/p>\n<p><strong>Biomea Fusion (BMEA)<\/strong> \u2014 Citizens reiterated its Market Outperform rating and set a US$7.00 price target.<\/p>\n<p><strong>Biomea Fusion (BMEA)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and set a US$4.00 price target.<\/p>\n<p><strong>BioNTech (BNTX)<\/strong> \u2014 Canaccord Genuity lowered its price target to US$132.00 from US$136.00 and retained its Buy rating.<\/p>\n<p><strong>BKV (BKV)<\/strong> \u2014 Truist Financial raised its price target to US$34.00 from US$33.00 and retained its Buy rating.<\/p>\n<p><strong>Black Hills (BKH)<\/strong> \u2014 Jefferies initiated coverage with a Buy rating and a US$87.00 price target.<\/p>\n<p><strong>Boise Cascade (BCC)<\/strong> \u2014 BofA Securities lowered its price target to US$80.00 from US$89.00 and retained its Underperform rating.<\/p>\n<p><strong>Boston Scientific (BSX)<\/strong> \u2014 Truist Financial lowered its price target to US$51.00 from US$57.00 and retained its Buy rating.<\/p>\n<p><strong>Bright Horizons Family Solutions (BFAM)<\/strong> \u2014 UBS Group lowered its price target to US$78.00 from US$88.00 and retained its Neutral rating.<\/p>\n<p><strong>Brinker International (EAT)<\/strong> \u2014 Jefferies upgraded the stock to Buy from Hold and raised its price target to US$255.00 from US$230.00.<\/p>\n<p><strong>Bruker (BRKR)<\/strong> \u2014 JPMorgan changed its rating on the stock to Neutral from Overweight and set a US$60.00 price target.<\/p>\n<p><strong>Bullish (BLSH)<\/strong> \u2014 Wells Fargo &amp; Company lowered its price target to US$35.00 from US$38.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Bumble (BMBL)<\/strong> \u2014 UBS Group raised its price target to US$6.05 from US$3.00 and retained its Neutral rating.<\/p>\n<p><strong>Camden Property Trust (CPT)<\/strong> \u2014 Barclays lowered its price target to US$114.00 from US$123.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Camden Property Trust (CPT)<\/strong> \u2014 UBS Group lowered its price target to US$101.00 from US$105.00 and retained its Neutral rating.<\/p>\n<p><strong>Canadian Natural Resources (CNQ)<\/strong> \u2014 Raymond James Financial downgraded the stock to Market Perform from Outperform.<\/p>\n<p><strong>Canadian Solar (CSIQ)<\/strong> \u2014 UBS Group lowered its price target to US$16.00 from US$25.00 and retained its Buy rating.<\/p>\n<p><strong>Caris Life Sciences (CAI)<\/strong> \u2014 JPMorgan raised its price target to US$35.00 from US$25.00 and retained its Overweight rating.<\/p>\n<p><strong>Carpenter Technology (CRS)<\/strong> \u2014 JPMorgan lowered its price target to US$520.00 from US$700.00 and retained its Overweight rating.<\/p>\n<p><strong>Carrier Global (CARR)<\/strong> \u2014 RBC Capital lowered its price target to US$72.00 from US$82.00 and retained its Outperform rating.<\/p>\n<p><strong>Carrier Global (CARR)<\/strong> \u2014 Goldman Sachs downgraded the stock to Neutral from Buy and lowered its price target to US$61.00 from US$74.00.<\/p>\n<p><strong>Caterpillar (CAT)<\/strong> \u2014 Oppenheimer lowered its price target to US$1,009.00 from US$1,118.00 and retained its Outperform rating.<\/p>\n<p><strong>Caterpillar (CAT)<\/strong> \u2014 Sanford C. Bernstein reiterated its Market Perform rating and set a US$749.00 price target.<\/p>\n<p><strong>Cenovus Energy (CVE)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating.<\/p>\n<p><strong>Centerspace (CSR)<\/strong> \u2014 UBS Group lowered its price target to US$65.00 from US$68.00 and retained its Neutral rating.<\/p>\n<p><strong>Century Aluminum (CENX)<\/strong> \u2014 Barclays initiated coverage with an Equal Weight rating and a US$40.00 price target.<\/p>\n<p><strong>Cheesecake Factory (CAKE)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n<p><strong>Chemours (CC)<\/strong> \u2014 Mizuho changed its rating on the stock to Neutral from Outperform and lowered its price target to US$15.00 from US$18.00.<\/p>\n<p><strong>Choice Hotels International (CHH)<\/strong> \u2014 Freedom Broker initiated coverage with a Buy rating and a US$117.00 price target.<\/p>\n<p><strong>Chord Energy (CHRD)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$192.00 price target.<\/p>\n<p><strong>Chord Energy (CHRD)<\/strong> \u2014 Wells Fargo &amp; Company lowered its price target to US$174.00 from US$175.00 and retained its Overweight rating.<\/p>\n<p><strong>Citigroup (C)<\/strong> \u2014 Evercore set a US$135.00 price target.<\/p>\n<p><strong>Citigroup (C)<\/strong> \u2014 Keefe, Bruyette &amp; Woods reiterated its Outperform rating.<\/p>\n<p><strong>Citigroup (C)<\/strong> \u2014 RBC Capital lowered its price target to US$135.00 from US$150.00 and retained its Outperform rating.<\/p>\n<p><strong>Citigroup (C)<\/strong> \u2014 TD Cowen lowered its price target to US$148.00 from US$150.00 and retained its Buy rating.<\/p>\n<p><strong>Citigroup (C)<\/strong> \u2014 UBS Group set a US$148.00 price target.<\/p>\n<p><strong>Citizens Financial Group (CFG)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$78.00 from US$84.00 and retained its Overweight rating.<\/p>\n<p><strong>Clean Harbors (CLH)<\/strong> \u2014 TD Cowen raised its price target to US$390.00 from US$380.00 and retained its Buy rating.<\/p>\n<p><strong>Clorox (CLX)<\/strong> \u2014 Citigroup lowered its price target to US$90.00 from US$97.00 and retained its Neutral rating.<\/p>\n<p><strong>CME Group (CME)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$315.00 from US$301.00 and retained its Overweight rating.<\/p>\n<p><strong>CMS Energy (CMS)<\/strong> \u2014 Truist Financial lowered its price target to US$77.00 from US$81.00 and retained its Buy rating.<\/p>\n<p><strong>CNX Resources (CNX)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$34.00 price target.<\/p>\n<p><strong>CocaCola (KO)<\/strong> \u2014 Citigroup raised its price target to US$102.00 from US$100.00 and retained its Buy rating.<\/p>\n<p><strong>Compass (COMP)<\/strong> \u2014 Citigroup initiated coverage with an Outperform rating.<\/p>\n<p><strong>Compass (COMP)<\/strong> \u2014 Citizens initiated coverage with a Market Outperform rating and a US$11.00 price target.<\/p>\n<p><strong>Compass (COMP)<\/strong> \u2014 Compass Point set a US$11.00 price target.<\/p>\n<p><strong>Comstock Resources (CRK)<\/strong> \u2014 Scotiabank initiated coverage with an Underperform rating.<\/p>\n<p><strong>Constellium (CSTM)<\/strong> \u2014 Barclays initiated coverage with an Equal Weight rating and a US$28.00 price target.<\/p>\n<p><strong>Core Scientific (CORZ)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating and set a US$39.00 price target.<\/p>\n<p><strong>Core Scientific (CORZ)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p><strong>Core Scientific (CORZ)<\/strong> \u2014 UBS Group reiterated its Market Outperform rating.<\/p>\n<p><strong>Coty (COTY)<\/strong> \u2014 Citigroup raised its price target to US$3.00 from US$2.80 and retained its Neutral rating.<\/p>\n<p><strong>Crescent Energy (CRGY)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n<p><strong>Crescent Energy (CRGY)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$18.00 price target.<\/p>\n<p><strong>Cullen\/Frost Bankers (CFR)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$167.00 from US$175.00 and retained its Neutral rating.<\/p>\n<p><strong>Cytokinetics (CYTK)<\/strong> \u2014 UBS Group reiterated its Buy rating and set a US$104.00 price target.<\/p>\n<p><strong>Delek US (DK)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$95.00 from US$82.00 and retained its Overweight rating.<\/p>\n<p><strong>Dell Technologies (DELL)<\/strong> \u2014 Barclays downgraded the stock to Equal Weight from Overweight and lowered its price target to US$574.00 from US$603.00.<\/p>\n<p><strong>DENTSPLY SIRONA (XRAY)<\/strong> \u2014 Leerink Partners lowered its price target to US$10.00 from US$14.00 and retained its Market Perform rating.<\/p>\n<p><strong>Devon Energy (DVN)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$61.00 price target.<\/p>\n<p><strong>Diamondback Energy (FANG)<\/strong> \u2014 RBC Capital reiterated its Outperform rating and set a US$240.00 price target.<\/p>\n<p><strong>Diamondback Energy (FANG)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$250.00 price target.<\/p>\n<p><strong>DigitalOcean (DOCN)<\/strong> \u2014 Oppenheimer raised its price target to US$220.00 from US$190.00 and retained its Outperform rating.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 BofA Securities lowered its price target to US$410.00 from US$455.00 and retained its Buy rating.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 BTIG Research reiterated its Buy rating and set a US$425.00 price target.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 Citigroup lowered its price target to US$308.00 from US$335.00 and retained its Neutral rating.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 KeyCorp reiterated its Sector Weight rating.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 Mizuho lowered its price target to US$380.00 from US$420.00 and retained its Outperform rating.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 Morgan Stanley lowered its price target to US$345.00 from US$357.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 Robert W. Baird lowered its price target to US$320.00 from US$325.00 and retained its Neutral rating.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 RBC Capital lowered its price target to US$320.00 from US$325.00 and retained its Sector Perform rating.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 Sanford C. Bernstein set a US$340.00 price target.<\/p>\n<p><strong>Domino&#8217;s Pizza (DPZ)<\/strong> \u2014 Wells Fargo &amp; Company lowered its price target to US$320.00 from US$350.00 and retained its Equal Weight rating.<\/p>\n<p><strong>DoorDash (DASH)<\/strong> \u2014 Guggenheim reiterated its Buy rating and set a US$255.00 price target.<\/p>\n<p><strong>Douglas Elliman (DOUG)<\/strong> \u2014 Citigroup initiated coverage with a Market Perform rating.<\/p>\n<p><strong>Douglas Elliman (DOUG)<\/strong> \u2014 Citizens initiated coverage with a Market Perform rating.<\/p>\n<p><strong>Dover (DOV)<\/strong> \u2014 RBC Capital lowered its price target to US$216.00 from US$227.00 and retained its Sector Perform rating.<\/p>\n<p><strong>DT Midstream (DTM)<\/strong> \u2014 Goldman Sachs reiterated its Sell rating and set a US$121.00 price target.<\/p>\n<p><strong>e.l.f. Beauty (ELF)<\/strong> \u2014 Citigroup raised its price target to US$130.00 from US$118.00 and retained its Buy rating.<\/p>\n<p><strong>East West Bancorp (EWBC)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$146.00 from US$152.00 and retained its Overweight rating.<\/p>\n<p><strong>Eaton (ETN)<\/strong> \u2014 RBC Capital raised its price target to US$526.00 from US$512.00 and retained its Outperform rating.<\/p>\n<p><strong>Edgewise Therapeutics (EWTX)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n<p><strong>Emerson Electric (EMR)<\/strong> \u2014 RBC Capital raised its price target to US$188.00 from US$179.00 and retained its Outperform rating.<\/p>\n<p><strong>Enerflex (EFXT)<\/strong> \u2014 RBC Capital raised its price target to US$35.00 from US$33.00 and retained its Outperform rating.<\/p>\n<p><strong>Enphase Energy (ENPH)<\/strong> \u2014 Morgan Stanley lowered its price target to US$24.00 from US$27.00 and retained its Underweight rating.<\/p>\n<p><strong>Enphase Energy (ENPH)<\/strong> \u2014 Susquehanna lowered its price target to US$35.00 from US$37.00 and retained its Neutral rating.<\/p>\n<p><strong>Entegris (ENTG)<\/strong> \u2014 Truist Financial initiated coverage with a Buy rating and a US$190.00 price target.<\/p>\n<p><strong>Envista (NVST)<\/strong> \u2014 Leerink Partners lowered its price target to US$32.00 from US$35.00 and retained its Outperform rating.<\/p>\n<p><strong>EOG Resources (EOG)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$144.00 price target.<\/p>\n<p><strong>EPR Properties (EPR)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p><strong>EQT (EQT)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$54.00 price target.<\/p>\n<p><strong>Equity Lifestyle Properties (ELS)<\/strong> \u2014 Barclays lowered its price target to US$66.00 from US$69.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Essex Property Trust (ESS)<\/strong> \u2014 Barclays lowered its price target to US$285.00 from US$297.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Essex Property Trust (ESS)<\/strong> \u2014 UBS Group lowered its price target to US$275.00 from US$286.00 and retained its Neutral rating.<\/p>\n<p><strong>Establishment Labs (ESTA)<\/strong> \u2014 Stifel set a US$85.00 price target.<\/p>\n<p><strong>Eton Pharmaceuticals (ETON)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and set a US$70.00 price target.<\/p>\n<p><strong>Evotec (EVO)<\/strong> \u2014 HC Wainwright reiterated its Buy rating and set a US$4.00 price target.<\/p>\n<p><strong>Expand Energy (EXE)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$111.00 price target.<\/p>\n<p><strong>FB Financial (FBK)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating and set a US$65.00 price target.<\/p>\n<p><strong>FB Financial (FBK)<\/strong> \u2014 Keefe, Bruyette &amp; Woods lowered its price target to US$64.00 from US$65.00 and retained its Outperform rating.<\/p>\n<p><strong>FB Financial (FBK)<\/strong> \u2014 Truist Financial set a US$64.00 price target.<\/p>\n<p><strong>Figma (FIG)<\/strong> \u2014 Stifel lowered its price target to US$22.00 from US$25.00 and retained its Hold rating.<\/p>\n<p><strong>First Financial Bankshares (FFIN)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$34.00 from US$35.00 and retained its Neutral rating.<\/p>\n<p><strong>First Financial Bankshares (FFIN)<\/strong> \u2014 Raymond James Financial initiated coverage with a Market Perform rating.<\/p>\n<p><strong>First Solar (FSLR)<\/strong> \u2014 Morgan Stanley raised its price target to US$326.00 from US$323.00 and retained its Overweight rating.<\/p>\n<p><strong>Flagstar Bank, National Association (FLG)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$16.00 from US$17.00 and retained its Overweight rating.<\/p>\n<p><strong>Flowserve (FLS)<\/strong> \u2014 RBC Capital lowered its price target to US$88.00 from US$94.00 and retained its Outperform rating.<\/p>\n<p><strong>Fluence Energy (FLNC)<\/strong> \u2014 Morgan Stanley lowered its price target to US$9.00 from US$15.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Fluence Energy (FLNC)<\/strong> \u2014 Susquehanna lowered its price target to US$13.00 from US$23.00 and retained its Positive rating.<\/p>\n<p><strong>Fortive (FTV)<\/strong> \u2014 RBC Capital lowered its price target to US$59.00 from US$63.00 and retained its Sector Perform rating.<\/p>\n<p><strong>Garmin (GRMN)<\/strong> \u2014 Arete initiated coverage with a Buy rating and a US$335.00 price target.<\/p>\n<p><strong>GE Vernova (GEV)<\/strong> \u2014 Susquehanna lowered its price target to US$1,270.00 from US$1,300.00 and retained its Positive rating.<\/p>\n<p><strong>General Dynamics (GD)<\/strong> \u2014 Sanford C. Bernstein lowered its price target to US$365.00 from US$407.00 and retained its Market Perform rating.<\/p>\n<p><strong>GFL Environmental (GFL)<\/strong> \u2014 Citigroup set a US$51.00 price target and retained its Buy rating.<\/p>\n<p><strong>Global Industrial (GIC)<\/strong> \u2014 Freedom Broker initiated coverage with a Hold rating and a US$39.00 price target.<\/p>\n<p><strong>Goosehead Insurance (GSHD)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating.<\/p>\n<p><strong>Graco (GGG)<\/strong> \u2014 RBC Capital lowered its price target to US$95.00 from US$96.00 and retained its Outperform rating.<\/p>\n<p><strong>Gulfport Energy (GPOR)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$217.00 price target.<\/p>\n<p><strong>GXO Logistics (GXO)<\/strong> \u2014 Goldman Sachs upgraded the stock to Buy from Neutral and set a US$61.00 price target.<\/p>\n<p><strong>Henry Schein (HSIC)<\/strong> \u2014 Leerink Partners lowered its price target to US$92.00 from US$96.00 and retained its Market Perform rating.<\/p>\n<p><strong>Hershey (HSY)<\/strong> \u2014 Jefferies reiterated its Hold rating and set a US$178.00 price target.<\/p>\n<p><strong>Hewlett Packard Enterprise (HPE)<\/strong> \u2014 Barclays downgraded the stock to Equal Weight from Overweight and lowered its price target to US$77.00 from US$83.00.<\/p>\n<p><strong>HF Sinclair (DINO)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$135.00 from US$93.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Hilton Worldwide (HLT)<\/strong> \u2014 Freedom Broker initiated coverage with a Buy rating and a US$359.00 price target.<\/p>\n<p><strong>Honeywell International (HON)<\/strong> \u2014 RBC Capital lowered its price target to US$270.00 from US$293.00 and retained its Outperform rating.<\/p>\n<p><strong>Hormel Foods (HRL)<\/strong> \u2014 Barclays reiterated its Overweight rating and lowered its price target to US$28.00 from US$30.00.<\/p>\n<p><strong>HubSpot (HUBS)<\/strong> \u2014 UBS Group reiterated its Hold rating.<\/p>\n<p><strong>Huntington Ingalls Industries (HII)<\/strong> \u2014 Sanford C. Bernstein lowered its price target to US$304.00 from US$327.00 and retained its Market Perform rating.<\/p>\n<p><strong>Hyatt Hotels (H)<\/strong> \u2014 Freedom Broker initiated coverage with a Buy rating and a US$192.00 price target.<\/p>\n<p><strong>IDEAYA Biosciences (IDYA)<\/strong> \u2014 Stifel resumed coverage with a Buy rating and a US$48.00 price target.<\/p>\n<p><strong>IDEX (IEX)<\/strong> \u2014 RBC Capital raised its price target to US$285.00 from US$280.00 and retained its Outperform rating.<\/p>\n<p><strong>IMAX (IMAX)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating and set a US$65.00 price target.<\/p>\n<p><strong>IMAX (IMAX)<\/strong> \u2014 Wedbush raised its price target to US$60.00 from US$54.00 and retained its Outperform rating.<\/p>\n<p><strong>Immatics N.V. (IMTX)<\/strong> \u2014 Stifel initiated coverage with a Buy rating and a US$15 price target.<\/p>\n<p><strong>ImmunityBio (IBRX)<\/strong> \u2014 Jefferies reiterated its Buy rating and set a US$14.00 price target.<\/p>\n<p><strong>ImmunityBio (IBRX)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating and set a US$16.00 price target.<\/p>\n<p><strong>Incyte (INCY)<\/strong> \u2014 Truist Financial raised its price target to US$115.00 from US$105.00 and retained its Hold rating.<\/p>\n<p><strong>Independence Realty Trust (IRT)<\/strong> \u2014 Barclays lowered its price target to US$19.00 from US$20.00 and retained its Overweight rating.<\/p>\n<p><strong>Independence Realty Trust (IRT)<\/strong> \u2014 UBS Group lowered its price target to US$17.00 from US$18.00 and retained its Buy rating.<\/p>\n<p><strong>Infinity Natural Resources (INR)<\/strong> \u2014 RBC Capital lowered its price target to US$21.00 from US$22.00 and retained its Outperform rating.<\/p>\n<p><strong>Infinity Natural Resources (INR)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$17.00 price target.<\/p>\n<p><strong>Ingredion (INGR)<\/strong> \u2014 Barclays lowered its price target to US$115.00 from US$118.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Innio (INIO)<\/strong> \u2014 Morgan Stanley lowered its price target to US$40.00 from US$47.00 and retained its Overweight rating.<\/p>\n<p><strong>Innovative Industrial Properties (IIPR)<\/strong> \u2014 Stifel initiated coverage with a Buy rating and a US$56.25 price target.<\/p>\n<p><strong>Inspire Medical Systems (INSP)<\/strong> \u2014 Truist Financial raised its price target to US$78.00 from US$62.00 and retained its Hold rating.<\/p>\n<p><strong>Integra LifeSciences (IART)<\/strong> \u2014 Truist Financial lowered its price target to US$15.00 from US$19.00 and retained its Hold rating.<\/p>\n<p><strong>Intercontinental Exchange (ICE)<\/strong> \u2014 Wells Fargo &amp; Company reiterated its Underweight rating and raised its price target to US$160.00 from US$159.00.<\/p>\n<p><strong>Invitation Home (INVH)<\/strong> \u2014 Barclays lowered its price target to US$35.00 from US$36.00 and retained its Overweight rating.<\/p>\n<p><strong>IQVIA (IQV)<\/strong> \u2014 Stifel raised its price target to US$303.00 from US$276.00 and retained its Buy rating.<\/p>\n<p><strong>J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 Sanford C. Bernstein lowered its price target to US$307.00 from US$329.00 and retained its Outperform rating.<\/p>\n<p><strong>Jasper Therapeutics (JSPR)<\/strong> \u2014 William Blair resumed coverage with an Outperform rating.<\/p>\n<p><strong>JD.com (JD)<\/strong> \u2014 Barclays lowered its price target to US$38.00 from US$41.00 and retained its Overweight rating.<\/p>\n<p><strong>JFrog (FROG)<\/strong> \u2014 UBS Group raised its price target to US$125.00 from US$120.00 and retained its Buy rating.<\/p>\n<p><strong>Johnson &amp; Johnson (JNJ)<\/strong> \u2014 Leerink Partners lowered its price target to US$272.00 from US$276.00 and retained its Outperform rating.<\/p>\n<p><strong>Johnson &amp; Johnson (JNJ)<\/strong> \u2014 RBC Capital lowered its price target to US$280.00 from US$290.00 and retained its Outperform rating.<\/p>\n<p><strong>Johnson &amp; Johnson (JNJ)<\/strong> \u2014 Sanford C. Bernstein reiterated its Market Perform rating.<\/p>\n<p><strong>Johnson &amp; Johnson (JNJ)<\/strong> \u2014 UBS Group set a US$270.00 price target.<\/p>\n<p><strong>Johnson &amp; Johnson (JNJ)<\/strong> \u2014 Wells Fargo &amp; Company lowered its price target to US$275.00 from US$282.00 and retained its Overweight rating.<\/p>\n<p><strong>Johnson Controls International (JCI)<\/strong> \u2014 RBC Capital raised its price target to US$165.00 from US$161.00 and retained its Sector Perform rating.<\/p>\n<p><strong>JPMorgan Chase &amp; Co. (JPM)<\/strong> \u2014 Barclays raised its price target to US$425.00 from US$420.00 and retained its Overweight rating.<\/p>\n<p><strong>JPMorgan Chase &amp; Co. (JPM)<\/strong> \u2014 Keefe, Bruyette &amp; Woods reiterated its Outperform rating.<\/p>\n<p><strong>JPMorgan Chase &amp; Co. (JPM)<\/strong> \u2014 Morgan Stanley raised its price target to US$377.00 from US$370.00 and retained its Equal Weight rating.<\/p>\n<p><strong>JPMorgan Chase &amp; Co. (JPM)<\/strong> \u2014 Robert W. Baird raised its price target to US$312.00 from US$305.00 and retained its Neutral rating.<\/p>\n<p><strong>JPMorgan Chase &amp; Co. (JPM)<\/strong> \u2014 RBC Capital reiterated its Outperform rating and set a US$370.00 price target.<\/p>\n<p><strong>JPMorgan Chase &amp; Co. (JPM)<\/strong> \u2014 Truist Financial raised its price target to US$361.00 from US$352.00 and retained its Hold rating.<\/p>\n<p><strong>Kaiser Aluminum (KALU)<\/strong> \u2014 Barclays initiated coverage with an Overweight rating and a US$180.00 price target.<\/p>\n<p><strong>Keurig Dr Pepper (KDP)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating.<\/p>\n<p><strong>Kinetik (KNTK)<\/strong> \u2014 RBC Capital raised its price target to US$58.00 from US$57.00 and retained its Outperform rating.<\/p>\n<p><strong>Kinetik (KNTK)<\/strong> \u2014 Goldman Sachs reiterated its Buy rating and set a US$58.00 price target.<\/p>\n<p><strong>Kirby (KEX)<\/strong> \u2014 JPMorgan initiated coverage with an Overweight rating and a US$200.00 price target.<\/p>\n<p><strong>Kontoor Brands (KTB)<\/strong> \u2014 Jefferies upgraded the stock to Buy from Hold and raised its price target to US$89.00 from US$82.00.<\/p>\n<p><strong>Kraft Heinz (KHC)<\/strong> \u2014 Jefferies reiterated its Hold rating and set a US$21.00 price target.<\/p>\n<p><strong>Kura Oncology (KURA)<\/strong> \u2014 Barclays set a US$24.00 price target.<\/p>\n<p><strong>Kura Oncology (KURA)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n<p><strong>Kura Oncology (KURA)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p><strong>Kura Oncology (KURA)<\/strong> \u2014 Deutsche Bank set a US$24.00 price target.<\/p>\n<p><strong>L3Harris Technologies (LHX)<\/strong> \u2014 Sanford C. Bernstein lowered its price target to US$318.00 from US$346.00 and retained its Outperform rating.<\/p>\n<p><strong>Lennox International (LII)<\/strong> \u2014 Oppenheimer lowered its price target to US$548.00 from US$575.00 and retained its Outperform rating.<\/p>\n<p><strong>Lennox International (LII)<\/strong> \u2014 RBC Capital lowered its price target to US$406.00 from US$469.00 and retained its Sector Perform rating.<\/p>\n<p><strong>Lennox International (LII)<\/strong> \u2014 Goldman Sachs downgraded the stock to Neutral from Buy and lowered its price target to US$390.00 from US$547.00.<\/p>\n<p><strong>Liberty Energy (LBRT)<\/strong> \u2014 Morgan Stanley lowered its price target to US$28.00 from US$30.00 and retained its Overweight rating.<\/p>\n<p><strong>Liftoff Mobile (LFTO)<\/strong> \u2014 Goldman Sachs reiterated its Buy rating and set a US$26.00 price target.<\/p>\n<p><strong>Liquidia (LQDA)<\/strong> \u2014 BTIG Research upgraded the stock to Buy from Neutral and set a US$70.00 price target.<\/p>\n<p><strong>Liquidia (LQDA)<\/strong> \u2014 Lifesci Capital upgraded the stock to Outperform from Market Perform and set a US$59.00 price target.<\/p>\n<p><strong>Liquidia (LQDA)<\/strong> \u2014 Needham &amp; Company LLC lowered its price target to US$58.00 from US$72.00 and retained its Buy rating.<\/p>\n<p><strong>Liquidia (LQDA)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$33.00 from US$30.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Live Oak Bancshares (LOB)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$41.00 from US$45.00 and retained its Neutral rating.<\/p>\n<p><strong>Lockheed Martin (LMT)<\/strong> \u2014 Sanford C. Bernstein lowered its price target to US$564.00 from US$629.00 and retained its Market Perform rating.<\/p>\n<p><strong>Lockheed Martin (LMT)<\/strong> \u2014 Vertical Research upgraded the stock to Buy from Hold and set a US$600.00 price target.<\/p>\n<p><strong>Louisiana-Pacific (LPX)<\/strong> \u2014 BofA Securities lowered its price target to US$85.00 from US$100.00 and retained its Buy rating.<\/p>\n<p><strong>M&amp;T Bank (MTB)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$255.00 from US$285.00 and retained its Overweight rating.<\/p>\n<p><strong>Madison Air Solutions (MAIR)<\/strong> \u2014 RBC Capital lowered its price target to US$35.00 from US$38.00 and retained its Outperform rating.<\/p>\n<p><strong>Madrigal Pharmaceuticals (MDGL)<\/strong> \u2014 UBS Group reiterated its Buy rating and set a US$735.00 price target.<\/p>\n<p><strong>Magnolia Oil &amp; Gas (MGY)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$31.00 price target.<\/p>\n<p><strong>Magnolia Oil &amp; Gas (MGY)<\/strong> \u2014 Wells Fargo &amp; Company lowered its price target to US$30.00 from US$36.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Manhattan Associates (MANH)<\/strong> \u2014 Stifel raised its price target to US$250.00 from US$225.00 and retained its Buy rating.<\/p>\n<p><strong>Manhattan Associates (MANH)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n<p><strong>Marathon Petroleum (MPC)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$560.00 from US$400.00 and retained its Overweight rating.<\/p>\n<p><strong>Marex Group plc Ordinary Shares (MRX)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n<p><strong>Marriott International (MAR)<\/strong> \u2014 Freedom Broker initiated coverage with a Buy rating and a US$408.00 price target.<\/p>\n<p><strong>Matador Resources (MTDR)<\/strong> \u2014 Truist Financial raised its price target to US$65.00 from US$59.00 and retained its Buy rating.<\/p>\n<p><strong>Matador Resources (MTDR)<\/strong> \u2014 Wells Fargo &amp; Company lowered its price target to US$76.00 from US$77.00 and retained its Overweight rating.<\/p>\n<p><strong>Mechanics Bancorp (MCHB)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$17.00 from US$18.00 and retained its Overweight rating.<\/p>\n<p><strong>Medallion Financial (MFIN)<\/strong> \u2014 Northland Securities set a US$13.25 price target.<\/p>\n<p><strong>MediaAlpha (MAX)<\/strong> \u2014 Goldman Sachs lowered its price target to US$10.50 from US$14.00 and retained its Neutral rating.<\/p>\n<p><strong>Medtronic (MDT)<\/strong> \u2014 Piper Sandler reiterated its Neutral rating.<\/p>\n<p><strong>Medtronic (MDT)<\/strong> \u2014 UBS Group reiterated its Cautious rating.<\/p>\n<p><strong>Meta Platforms (META)<\/strong> \u2014 Guggenheim raised its price target to US$850.00 from US$700.00 and retained its Buy rating.<\/p>\n<p><strong>Meta Platforms (META)<\/strong> \u2014 Goldman Sachs lowered its price target to US$762.00 from US$860.00 and retained its Buy rating.<\/p>\n<p><strong>Meta Platforms (META)<\/strong> \u2014 UBS Group raised its price target to US$884.00 from US$715.00 and retained its Buy rating.<\/p>\n<p><strong>Microsoft (MSFT)<\/strong> \u2014 Jefferies reiterated its Buy rating and set a US$650.00 price target.<\/p>\n<p><strong>Mid-America Apartment Communities (MAA)<\/strong> \u2014 Barclays lowered its price target to US$136.00 from US$146.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Mid-America Apartment Communities (MAA)<\/strong> \u2014 UBS Group lowered its price target to US$123.00 from US$129.00 and retained its Neutral rating.<\/p>\n<p><strong>Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 Stifel set a US$156.00 price target.<\/p>\n<p><strong>Molson Coors Beverage (TAP)<\/strong> \u2014 Citigroup lowered its price target to US$40.00 from US$42.00 and retained its Neutral rating.<\/p>\n<p><strong>Moody&#8217;s (MCO)<\/strong> \u2014 JPMorgan lowered its price target to US$555.00 from US$570.00 and retained its Overweight rating.<\/p>\n<p><strong>Morgan Stanley (MS)<\/strong> \u2014 Goldman Sachs reiterated its Neutral rating.<\/p>\n<p><strong>MSCI (MSCI)<\/strong> \u2014 JPMorgan lowered its price target to US$685.00 from US$700.00 and retained its Overweight rating.<\/p>\n<p><strong>Mueller Water Products (MWA)<\/strong> \u2014 Oppenheimer lowered its price target to US$30.00 from US$32.00 and retained its Outperform rating.<\/p>\n<p><strong>Murphy Oil (MUR)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating.<\/p>\n<p><strong>Murphy Oil (MUR)<\/strong> \u2014 Mizuho raised its price target to US$44.00 from US$41.00 and retained its Neutral rating.<\/p>\n<p><strong>Murphy Oil (MUR)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$41.00 price target.<\/p>\n<p><strong>Murphy Oil (MUR)<\/strong> \u2014 UBS Group raised its price target to US$40.00 from US$38.00 and retained its Neutral rating.<\/p>\n<p><strong>Natera (NTRA)<\/strong> \u2014 JPMorgan raised its price target to US$460.00 from US$360.00 and retained its Overweight rating.<\/p>\n<p><strong>NetApp (NTAP)<\/strong> \u2014 Barclays downgraded the stock to Equal Weight from Overweight and set a US$219.00 price target.<\/p>\n<p><strong>NextEra Energy (NEE)<\/strong> \u2014 Morgan Stanley lowered its price target to US$110.00 from US$111.00 and retained its Overweight rating.<\/p>\n<p><strong>Nextpower (NXT)<\/strong> \u2014 Susquehanna lowered its price target to US$150.00 from US$157.00 and retained its Positive rating.<\/p>\n<p><strong>NiSource (NI)<\/strong> \u2014 Citigroup lowered its price target to US$45.00 from US$49.00 and retained its Neutral rating.<\/p>\n<p><strong>Northern Oil and Gas (NOG)<\/strong> \u2014 Mizuho raised its price target to US$30.00 from US$29.00 and retained its Neutral rating.<\/p>\n<p><strong>Northern Oil and Gas (NOG)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$27.00 price target.<\/p>\n<p><strong>Northrop Grumman (NOC)<\/strong> \u2014 Sanford C. Bernstein lowered its price target to US$556.00 from US$620.00 and retained its Market Perform rating.<\/p>\n<p><strong>nVent Electric (NVT)<\/strong> \u2014 RBC Capital raised its price target to US$208.00 from US$200.00 and retained its Outperform rating.<\/p>\n<p><strong>Occidental Petroleum (OXY)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating and set a US$68.00 price target.<\/p>\n<p><strong>Occidental Petroleum (OXY)<\/strong> \u2014 UBS Group raised its price target to US$73.00 from US$67.00 and retained its Neutral rating.<\/p>\n<p><strong>Omeros (OMER)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating and set a US$22.00 price target.<\/p>\n<p><strong>Oncology Institute (STLN)<\/strong> \u2014 Needham &amp; Company LLC raised its price target to US$9.00 from US$7.00 and retained its Buy rating.<\/p>\n<p><strong>Oric Pharmaceuticals (ORIC)<\/strong> \u2014 JPMorgan raised its price target to US$26.00 from US$23.00 and retained its Overweight rating.<\/p>\n<p><strong>Ovintiv (OVV)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$82.00 from US$79.00 and retained its Overweight rating.<\/p>\n<p><strong>Parker-Hannifin (PH)<\/strong> \u2014 TD Cowen raised its price target to US$950.00 from US$850.00 and retained its Hold rating.<\/p>\n<p><strong>Parker-Hannifin (PH)<\/strong> \u2014 UBS Group set a US$950.00 price target.<\/p>\n<p><strong>Pembina Pipeline (PBA)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating.<\/p>\n<p><strong>Pentair (PNR)<\/strong> \u2014 RBC Capital lowered its price target to US$61.00 from US$73.00 and retained its Sector Perform rating.<\/p>\n<p><strong>Pentair (PNR)<\/strong> \u2014 TD Cowen upgraded the stock to Hold from Sell and lowered its price target to US$55.00 from US$65.00.<\/p>\n<p><strong>Pentair (PNR)<\/strong> \u2014 William Blair set a US$50.00 price target.<\/p>\n<p><strong>Permian Resources (PR)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$29.00 price target.<\/p>\n<p><strong>Permian Resources (PR)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$28.00 from US$27.00 and retained its Overweight rating.<\/p>\n<p><strong>Phathom Pharmaceuticals (PHAT)<\/strong> \u2014 Jefferies reiterated its Buy rating and set a US$16.00 price target.<\/p>\n<p><strong>Phillips 66 (PSX)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$345.00 from US$335.00 and retained its Overweight rating.<\/p>\n<p><strong>Playtika (PLTK)<\/strong> \u2014 Citigroup lowered its price target to US$3.50 from US$4.00 and retained its Buy rating.<\/p>\n<p><strong>Plug Power (PLUG)<\/strong> \u2014 Morgan Stanley reiterated its Underweight rating and set a US$1.20 price target.<\/p>\n<p><strong>Plug Power (PLUG)<\/strong> \u2014 Susquehanna lowered its price target to US$1.75 from US$2.50 and retained its Neutral rating.<\/p>\n<p><strong>Porch Group (PRCH)<\/strong> \u2014 B. Riley Financial raised its price target to US$24.00 from US$21.00 and retained its Buy rating.<\/p>\n<p><strong>Porch Group (PRCH)<\/strong> \u2014 Craig Hallum raised its price target to US$22.00 from US$20.00 and retained its Buy rating.<\/p>\n<p><strong>Prelude Therapeutics (PRLD)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p><strong>ProPetro (PUMP)<\/strong> \u2014 Morgan Stanley lowered its price target to US$12.00 from US$13.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Prosperity Bancshares (PB)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$78.00 from US$85.00 and retained its Overweight rating.<\/p>\n<p><strong>PVH (PVH)<\/strong> \u2014 Jefferies raised its price target to US$95.00 from US$91.00 and retained its Buy rating.<\/p>\n<p><strong>Qiagen (QGEN)<\/strong> \u2014 JPMorgan raised its price target to US$55.00 from US$50.00 and retained its Overweight rating.<\/p>\n<p><strong>Qnity Electronics (Q)<\/strong> \u2014 Truist Financial initiated coverage with a Buy rating and a US$170.00 price target.<\/p>\n<p><strong>Ralliant (RAL)<\/strong> \u2014 RBC Capital lowered its price target to US$72.00 from US$73.00 and retained its Sector Perform rating.<\/p>\n<p><strong>Ralliant Corporation (RAL)<\/strong> \u2014 Seaport Research Partners upgraded the stock to Buy from Neutral and set a US$88 price target.<\/p>\n<p><strong>Range Resources (RRC)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$42.00 price target.<\/p>\n<p><strong>Real REMAX Group (REAX)<\/strong> \u2014 Citigroup initiated coverage with a Market Outperform rating.<\/p>\n<p><strong>Real REMAX Group (REAX)<\/strong> \u2014 Citizens initiated coverage with a Market Outperform rating and a US$40.00 price target.<\/p>\n<p><strong>Real REMAX Group (REAX)<\/strong> \u2014 Compass Point set a US$40.00 price target.<\/p>\n<p><strong>Reddit (RDDT)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p><strong>Regions Financial (RF)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$32.00 from US$35.00 and retained its Overweight rating.<\/p>\n<p><strong>Reliance (RS)<\/strong> \u2014 Barclays initiated coverage with an Equal Weight rating and a US$420.00 price target.<\/p>\n<p><strong>Revolution Medicines (RVMD)<\/strong> \u2014 RBC Capital raised its price target to US$260.00 from US$259.00 and retained its Outperform rating.<\/p>\n<p><strong>Robinhood Markets (HOOD)<\/strong> \u2014 Wells Fargo &amp; Company lowered its price target to US$120.00 from US$125.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Roblox (RBLX)<\/strong> \u2014 DA Davidson raised its price target to US$50.00 from US$40.00 and retained its Neutral rating.<\/p>\n<p><strong>Roblox (RBLX)<\/strong> \u2014 JPMorgan raised its price target to US$53.00 from US$40.00 and retained its Neutral rating.<\/p>\n<p><strong>Roblox (RBLX)<\/strong> \u2014 UBS Group raised its price target to US$53.00 from US$45.00 and retained its Neutral rating.<\/p>\n<p><strong>Rollins (ROL)<\/strong> \u2014 UBS Group lowered its price target to US$36.00 from US$43.00 and retained its Neutral rating.<\/p>\n<p><strong>S&amp;P Global (SPGI)<\/strong> \u2014 JPMorgan lowered its price target to US$520.00 from US$530.00 and retained its Overweight rating.<\/p>\n<p><strong>Safehold (SAFE)<\/strong> \u2014 Citizens changed its rating on the stock to Market Perform from Outperform.<\/p>\n<p><strong>Safehold (SAFE)<\/strong> \u2014 UBS Group downgraded the stock to Market Perform.<\/p>\n<p><strong>Seadrill (SDRL)<\/strong> \u2014 BWS Financial reiterated its Buy rating and set a US$80.00 price target.<\/p>\n<p><strong>Seaport Therapeutics (SPTX)<\/strong> \u2014 Canaccord Genuity initiated coverage with a Buy rating and a US$28.00 price target.<\/p>\n<p><strong>Sempra Energy (SRE)<\/strong> \u2014 Truist Financial lowered its price target to US$94.00 from US$96.00 and retained its Buy rating.<\/p>\n<p><strong>SentinelOne (S)<\/strong> \u2014 Robert W. Baird raised its price target to US$28.00 from US$25.00 and retained its Outperform rating.<\/p>\n<p><strong>ServiceNow (NOW)<\/strong> \u2014 Citigroup reiterated its Buy rating and raised its price target to US$170.00 from US$154.00.<\/p>\n<p><strong>Shoals Technologies Group (SHLS)<\/strong> \u2014 Jefferies lowered its price target to US$11.00 from US$12.00 and retained its Buy rating.<\/p>\n<p><strong>Shopify (SHOP)<\/strong> \u2014 Jefferies reiterated its Buy rating.<\/p>\n<p><strong>Shopify (SHOP)<\/strong> \u2014 Robert W. Baird raised its price target to US$190.00 from US$160.00 and retained its Outperform rating.<\/p>\n<p><strong>Shopify (SHOP)<\/strong> \u2014 Stifel Nicolaus raised its price target to US$210.00 from US$180.00 and retained its Buy rating.<\/p>\n<p><strong>SiBone (SIBN)<\/strong> \u2014 Truist Financial raised its price target to US$25.00 from US$23.00 and retained its Buy rating.<\/p>\n<p><strong>Silver Standard Resources (SSRM)<\/strong> \u2014 UBS Group lowered its price target to US$39.00 from US$41.00 and retained its Buy rating.<\/p>\n<p><strong>SM Energy (SM)<\/strong> \u2014 Scotiabank initiated coverage with a Sector Perform rating and a US$39.00 price target.<\/p>\n<p><strong>Sol-Gel Technologies (SLGL)<\/strong> \u2014 Cantor Fitzgerald initiated coverage with an Overweight rating.<\/p>\n<p><strong>SolarEdge Technologies (SEDG)<\/strong> \u2014 Susquehanna lowered its price target to US$32.00 from US$38.00 and retained its Neutral rating.<\/p>\n<p><strong>Sotera Health (SHC)<\/strong> \u2014 JPMorgan changed its rating on the stock to Underweight from Neutral and set a US$17.00 price target.<\/p>\n<p><strong>South Bow (SOBO)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating.<\/p>\n<p><strong>SpaceX (SPCX)<\/strong> \u2014 Raymond James Financial reiterated its Strong-Buy rating.<\/p>\n<p><strong>Sphere Entertainment (SPHR)<\/strong> \u2014 Guggenheim lowered its price target to US$180.00 from US$208.00 and retained its Buy rating.<\/p>\n<p><strong>Sprout Social (SPT)<\/strong> \u2014 Stifel raised its price target to US$14.00 from US$12.00 and retained its Buy rating.<\/p>\n<p><strong>SPS Commerce (SPSC)<\/strong> \u2014 Stifel raised its price target to US$85.00 from US$70.00 and retained its Hold rating.<\/p>\n<p><strong>Standex International (SXI)<\/strong> \u2014 JPMorgan initiated coverage with a Neutral rating and a US$320.00 price target.<\/p>\n<p><strong>Stem (STEM)<\/strong> \u2014 Susquehanna lowered its price target to US$4.50 from US$7.50 and retained its Neutral rating.<\/p>\n<p><strong>Sterling Infrastructure (STRL)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating and set a US$742.00 price target.<\/p>\n<p><strong>Sun Communities (SUI)<\/strong> \u2014 Barclays lowered its price target to US$143.00 from US$147.00 and retained its Overweight rating.<\/p>\n<p><strong>Sunrun (RUN)<\/strong> \u2014 Morgan Stanley lowered its price target to US$10.00 from US$15.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Sunrun (RUN)<\/strong> \u2014 Susquehanna lowered its price target to US$13.00 from US$15.00 and retained its Positive rating.<\/p>\n<p><strong>Sylvamo (SLVM)<\/strong> \u2014 BofA Securities lowered its price target to US$42.00 from US$45.00 and retained its Neutral rating.<\/p>\n<p><strong>T. Rowe Price Group (TROW)<\/strong> \u2014 Barclays lowered its price target to US$102.00 from US$103.00 and retained its Underweight rating.<\/p>\n<p><strong>Take-Two Interactive Software (TTWO)<\/strong> \u2014 Raymond James Financial reiterated its Strong-Buy rating.<\/p>\n<p><strong>Tamboran Resources (TBN)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$70.00 price target.<\/p>\n<p><strong>Teleflex (TFX)<\/strong> \u2014 Truist Financial lowered its price target to US$142.00 from US$150.00 and retained its Hold rating.<\/p>\n<p><strong>Tempus AI (TEM)<\/strong> \u2014 JPMorgan raised its price target to US$70.00 from US$45.00 and retained its Neutral rating.<\/p>\n<p><strong>Tenaris (TS)<\/strong> \u2014 Morgan Stanley raised its price target to US$62.00 from US$60.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Texas Roadhouse (TXRH)<\/strong> \u2014 Barclays downgraded the stock to Cautious from Equal Weight.<\/p>\n<p><strong>Texas Roadhouse (TXRH)<\/strong> \u2014 Jefferies upgraded the stock to Buy from Hold and raised its price target to US$190.00 from US$186.00.<\/p>\n<p><strong>Texas Roadhouse (TXRH)<\/strong> \u2014 Vertical Research upgraded the stock to Buy.<\/p>\n<p><strong>The Goldman Sachs Group (GS)<\/strong> \u2014 Keefe, Bruyette &amp; Woods lowered its price target to US$1,100.00 from US$1,130.00 and retained its Market Perform rating.<\/p>\n<p><strong>The Goldman Sachs Group (GS)<\/strong> \u2014 RBC Capital lowered its price target to US$1,010.00 from US$1,220.00 and retained its Sector Perform rating.<\/p>\n<p><strong>Trade Desk (TTD)<\/strong> \u2014 UBS Group lowered its price target to US$15.00 from US$16.00 and retained its Buy rating.<\/p>\n<p><strong>Trane Technologies (TT)<\/strong> \u2014 RBC Capital raised its price target to US$502.00 from US$496.00 and retained its Sector Perform rating.<\/p>\n<p><strong>Trane Technologies (TT)<\/strong> \u2014 Goldman Sachs upgraded the stock to Buy from Neutral and raised its price target to US$565.00 from US$548.00.<\/p>\n<p><strong>Twilio (TWLO)<\/strong> \u2014 BofA Securities raised its price target to US$320.00 from US$270.00 and retained its Buy rating.<\/p>\n<p><strong>Twilio (TWLO)<\/strong> \u2014 Stifel set a US$325.00 price target.<\/p>\n<p><strong>United Dominion Realty Trust (UDR)<\/strong> \u2014 Barclays lowered its price target to US$44.00 from US$46.00 and retained its Overweight rating.<\/p>\n<p><strong>United Dominion Realty Trust (UDR)<\/strong> \u2014 UBS Group lowered its price target to US$39.00 from US$41.00 and retained its Buy rating.<\/p>\n<p><strong>United Rentals (URI)<\/strong> \u2014 Sanford C. Bernstein reiterated its Outperform rating and set a US$1,215.00 price target.<\/p>\n<p><strong>United Therapeutics (UTHR)<\/strong> \u2014 Jefferies reiterated its Buy rating and set a US$728.00 price target.<\/p>\n<p><strong>UnitedHealth Group (UNH)<\/strong> \u2014 Barclays lowered its price target to US$440.00 from US$441.00 and retained its Overweight rating.<\/p>\n<p><strong>UnitedHealth Group (UNH)<\/strong> \u2014 KeyCorp reiterated its Overweight rating.<\/p>\n<p><strong>UnitedHealth Group (UNH)<\/strong> \u2014 Piper Sandler raised its price target to US$504.00 from US$502.00 and retained its Overweight rating.<\/p>\n<p><strong>UnitedHealth Group (UNH)<\/strong> \u2014 Robert W. Baird lowered its price target to US$427.00 from US$453.00 and retained its Neutral rating.<\/p>\n<p><strong>UnitedHealth Group (UNH)<\/strong> \u2014 Sanford C. Bernstein reiterated its Outperform rating.<\/p>\n<p><strong>Unity Software (U)<\/strong> \u2014 Wedbush raised its price target to US$55.00 from US$50.00 and retained its Outperform rating.<\/p>\n<p><strong>Valero Energy (VLO)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target to US$485.00 from US$389.00 and retained its Overweight rating.<\/p>\n<p><strong>Valvoline (VVV)<\/strong> \u2014 TD Cowen lowered its price target to US$40.00 from US$45.00 and retained its Buy rating.<\/p>\n<p><strong>Valvoline (VVV)<\/strong> \u2014 UBS Group set a US$40.00 price target.<\/p>\n<p><strong>Veeco Instruments (VECO)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating and set a US$24.00 price target.<\/p>\n<p><strong>Verastem (VSTM)<\/strong> \u2014 Jefferies reiterated its Buy rating and set a US$13.00 price target.<\/p>\n<p><strong>Vericel (VCEL)<\/strong> \u2014 Truist Financial lowered its price target to US$52.00 from US$58.00 and retained its Buy rating.<\/p>\n<p><strong>Vertiv (VRT)<\/strong> \u2014 RBC Capital lowered its price target to US$323.00 from US$337.00 and retained its Outperform rating.<\/p>\n<p><strong>Veru (VERU)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n<p><strong>Victory Capital (VCTR)<\/strong> \u2014 Barclays raised its price target to US$121.00 from US$112.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Viking Therapeutics (VKTX)<\/strong> \u2014 UBS Group initiated coverage with a Buy rating.<\/p>\n<p><strong>Viper Energy (VNOM)<\/strong> \u2014 Scotiabank initiated coverage with an Outperform rating and a US$54.00 price target.<\/p>\n<p><strong>Viper Energy (VNOM)<\/strong> \u2014 Truist Financial raised its price target to US$53.00 from US$52.00 and retained its Buy rating.<\/p>\n<p><strong>Virtus Investment Partners (VRTS)<\/strong> \u2014 Barclays lowered its price target to US$117.00 from US$135.00 and retained its Underweight rating.<\/p>\n<p><strong>Vivmark Residential Common Shares of Beneficial Interest (VMRK)<\/strong> \u2014 Barclays lowered its price target to US$74.00 from US$75.00 and retained its Equal Weight rating.<\/p>\n<p><strong>Vivmark Residential Common Shares of Beneficial Interest (VMRK)<\/strong> \u2014 UBS Group lowered its price target to US$71.00 from US$75.00 and retained its Buy rating.<\/p>\n<p><strong>vTv Therapeutics (VTVT)<\/strong> \u2014 BTIG Research reiterated its Buy rating and set a US$57.00 price target.<\/p>\n<p><strong>Vylor (VYLR)<\/strong> \u2014 BNP Paribas Exane initiated coverage with a Neutral rating and a US$75.00 price target.<\/p>\n<p><strong>Vylor (VYLR)<\/strong> \u2014 Deutsche Bank initiated coverage with a Buy rating and a US$90.00 price target.<\/p>\n<p><strong>W.W. Grainger (GWW)<\/strong> \u2014 RBC Capital lowered its price target to US$1,427.00 from US$1,428.00 and retained its Sector Perform rating.<\/p>\n<p><strong>Watts Water Technologies (WTS)<\/strong> \u2014 RBC Capital reiterated its Sector Perform rating and set a US$417.00 price target.<\/p>\n<p><strong>Weatherford International (WFRD)<\/strong> \u2014 Goldman Sachs lowered its price target to US$94.00 from US$106.00 and retained its Neutral rating.<\/p>\n<p><strong>Wells Fargo &amp; Company (WFC)<\/strong> \u2014 Citigroup lowered its price target to US$88.00 from US$90.00 and retained its Neutral rating.<\/p>\n<p><strong>Wells Fargo &amp; Company (WFC)<\/strong> \u2014 Keefe, Bruyette &amp; Woods lowered its price target to US$90.00 from US$94.00 and retained its Market Perform rating.<\/p>\n<p><strong>Wells Fargo &amp; Company (WFC)<\/strong> \u2014 Morgan Stanley lowered its price target to US$101.00 from US$102.00 and retained its Overweight rating.<\/p>\n<p><strong>Wells Fargo &amp; Company (WFC)<\/strong> \u2014 RBC Capital lowered its price target to US$92.00 from US$100.00 and retained its Outperform rating.<\/p>\n<p><strong>WESCO International (WCC)<\/strong> \u2014 RBC Capital raised its price target to US$435.00 from US$430.00 and retained its Outperform rating.<\/p>\n<p><strong>Western Union (WU)<\/strong> \u2014 JPMorgan lowered its price target to US$7.00 from US$8.00 and retained its Underweight rating.<\/p>\n<p><strong>Western Union (WU)<\/strong> \u2014 Monness Crespi &amp; Hardt upgraded the stock to Neutral from Sell.<\/p>\n<p><strong>Western Union (WU)<\/strong> \u2014 Susquehanna reiterated its Neutral rating and set a US$7.00 price target.<\/p>\n<p><strong>Weyerhaeuser (WY)<\/strong> \u2014 BofA Securities upgraded the stock to Buy from Neutral and lowered its price target to US$25.00 from US$28.00.<\/p>\n<p><strong>Williams Companies (WMB)<\/strong> \u2014 Jefferies lowered its price target to US$83.00 from US$85.00 and retained its Buy rating.<\/p>\n<p><strong>Workday (WDAY)<\/strong> \u2014 Mizuho set a US$210.00 price target.<\/p>\n<p><strong>Workday (WDAY)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n<p><strong>Workday (WDAY)<\/strong> \u2014 UBS Group lowered its price target to US$210.00 from US$220.00 and retained its Neutral rating.<\/p>\n<p><strong>Wyndham Hotels &amp; Resorts (WH)<\/strong> \u2014 Freedom Broker initiated coverage with a Buy rating and a US$88.00 price target.<\/p>\n<p><strong>X-Energy (XE)<\/strong> \u2014 Morgan Stanley lowered its price target to US$34.00 from US$41.00 and retained its Overweight rating.<\/p>\n<p><strong>Xcel Energy (XEL)<\/strong> \u2014 Truist Financial lowered its price target to US$87.00 from US$88.00 and retained its Buy rating.<\/p>\n<p><strong>Xylem (XYL)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating and lowered its price target to US$150.00 from US$158.00.<\/p>\n<p><strong>Xylem (XYL)<\/strong> \u2014 RBC Capital lowered its price target to US$135.00 from US$164.00 and retained its Outperform rating.<\/p>\n<p><strong>Zions Bancorporation, N.A. (ZION)<\/strong> \u2014 Cantor Fitzgerald lowered its price target to US$76.00 from US$80.00 and retained its Overweight rating.<\/p>\n<p><strong>ZTO Express (Cayman) (ZTO)<\/strong> \u2014 Goldman Sachs downgraded the stock to Neutral from Buy.<\/p>\n<p><strong>Zurn Elkay Water Solutions Cor (ZWS)<\/strong> \u2014 RBC Capital lowered its price target to US$54.00 from US$58.00 and retained its Sector Perform rating.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Analyst Ratings (USA) Analyst sentiment for today&#8217;s updates is selective and cautious. Target cuts outnumbered increases, especially among banks, technology hardware and consumer stocks,&hellip;<\/p>\n","protected":false},"author":3,"featured_media":5042,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76225","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>U.S. Analyst Updates: October 14th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Analyst Updates: October 14th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Analyst sentiment for today&#8217;s updates is selective and cautious. Target cuts outnumbered increases, especially among banks, technology hardware and consumer stocks,&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T02:09:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2021\/03\/JPMorgan-Chase_Featured-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"30 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"U.S. Analyst Updates: October 14th, 2026\",\"datePublished\":\"2026-10-15T02:09:25+00:00\",\"dateModified\":\"2026-10-15T02:09:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/\"},\"wordCount\":6803,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/\",\"name\":\"U.S. Analyst Updates: October 14th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-15T02:09:25+00:00\",\"dateModified\":\"2026-10-15T02:09:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. Analyst Updates: October 14th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"U.S. Analyst Updates: October 14th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/","og_locale":"en_US","og_type":"article","og_title":"U.S. Analyst Updates: October 14th, 2026","og_description":"Analyst Ratings (USA) Analyst sentiment for today&#8217;s updates is selective and cautious. Target cuts outnumbered increases, especially among banks, technology hardware and consumer stocks,&hellip;","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-15T02:09:25+00:00","og_image":[{"width":1900,"height":900,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2021\/03\/JPMorgan-Chase_Featured-Image.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"30 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"U.S. Analyst Updates: October 14th, 2026","datePublished":"2026-10-15T02:09:25+00:00","dateModified":"2026-10-15T02:09:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/"},"wordCount":6803,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/","name":"U.S. Analyst Updates: October 14th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-15T02:09:25+00:00","dateModified":"2026-10-15T02:09:25+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-14th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"U.S. Analyst Updates: October 14th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76225"}],"version-history":[{"count":4,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76225\/revisions"}],"predecessor-version":[{"id":76230,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76225\/revisions\/76230"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/5042"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}